On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.

The US Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC News reported.

Medically reviewed by Sohaib Imtiaz, MD While probiotics are often associated with digestive health, research shows their ...

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

Mefenamic acid, a common anti-inflammatory drug already approved for pain management, has been found to significantly reduce ...

The negative health impacts of alcohol have been in the spotlight since the surgeon general’s recent advisory, and now ...

Phosphine gas exposure can cause symptoms including nausea, vomiting, abdominal pain, diarrhea ... the first few hours after you inhale phosphine. More severe symptoms, such as cardiovascular damage, ...